Cargando…

A pilot study assessing the addition of a Quit and Win program to pharmacist-led intensive smoking cessation therapy in a predominantly underserved, minority population

INTRODUCTION: Quit and Win programs (Q&W) have been shown to improve smoking cessation rates by offering potential rewards to encourage smoking cessation. However, few studies have combined Q&W with intensive smoking cessation programs including behavioral counseling and pharmacotherapy, or...

Descripción completa

Detalles Bibliográficos
Autores principales: Evoy, Kirk E., Ford, Kentya H., Nduaguba, Sabina 0., Taylor, Amber, Thomas, Lindsay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Publishing on behalf of the European Network for Smoking and Tobacco Prevention (ENSP) 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205166/
https://www.ncbi.nlm.nih.gov/pubmed/32411906
http://dx.doi.org/10.18332/tpc/113356
_version_ 1783530191911387136
author Evoy, Kirk E.
Ford, Kentya H.
Nduaguba, Sabina 0.
Taylor, Amber
Thomas, Lindsay
author_facet Evoy, Kirk E.
Ford, Kentya H.
Nduaguba, Sabina 0.
Taylor, Amber
Thomas, Lindsay
author_sort Evoy, Kirk E.
collection PubMed
description INTRODUCTION: Quit and Win programs (Q&W) have been shown to improve smoking cessation rates by offering potential rewards to encourage smoking cessation. However, few studies have combined Q&W with intensive smoking cessation programs including behavioral counseling and pharmacotherapy, or studied Q&W in underserved, minority populations. This study was conducted to assess the impact on smoking cessation rates of adding a Q&W to intensive smoking cessation therapy in a largely underserved, minority population. METHODS: This was a single-center, prospective, open-label controlled study. Current smokers received pharmacist-led behavioral counseling and smoking cessation pharmacotherapy. Intervention group patients who successfully quit (verified by self-report and exhaled carbon monoxide) at 1 month and 3 months post-quit date were entered into a draw for $1000. The control group received the same smoking cessation services, but without a monetary incentive. RESULTS: Enrollment was 111 patients (N=85 in the intervention group), made up of predominantly underserved (82% had annual household income <$25000), minority (69.1%), and female (58%) patients. Groups were similar except the intervention group had lower educational and income levels, while the control group was more likely to smoke more than 1 pack per day. Quit rates at 3 months were 27% and 19% in the intervention and control groups, respectively (p=0.22). Female gender (OR=2.84; p=0.04) and Fagerström score (OR=0.71; p<0.01) were significant predictors of quitting. CONCLUSIONS: The addition of Q&W to intensive smoking cessation services increased clinic referrals and numerically improved cessation rates, although this difference was not statistically significant, possibly due to high attrition of the study.
format Online
Article
Text
id pubmed-7205166
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher European Publishing on behalf of the European Network for Smoking and Tobacco Prevention (ENSP)
record_format MEDLINE/PubMed
spelling pubmed-72051662020-05-14 A pilot study assessing the addition of a Quit and Win program to pharmacist-led intensive smoking cessation therapy in a predominantly underserved, minority population Evoy, Kirk E. Ford, Kentya H. Nduaguba, Sabina 0. Taylor, Amber Thomas, Lindsay Tob Prev Cessat Research Paper INTRODUCTION: Quit and Win programs (Q&W) have been shown to improve smoking cessation rates by offering potential rewards to encourage smoking cessation. However, few studies have combined Q&W with intensive smoking cessation programs including behavioral counseling and pharmacotherapy, or studied Q&W in underserved, minority populations. This study was conducted to assess the impact on smoking cessation rates of adding a Q&W to intensive smoking cessation therapy in a largely underserved, minority population. METHODS: This was a single-center, prospective, open-label controlled study. Current smokers received pharmacist-led behavioral counseling and smoking cessation pharmacotherapy. Intervention group patients who successfully quit (verified by self-report and exhaled carbon monoxide) at 1 month and 3 months post-quit date were entered into a draw for $1000. The control group received the same smoking cessation services, but without a monetary incentive. RESULTS: Enrollment was 111 patients (N=85 in the intervention group), made up of predominantly underserved (82% had annual household income <$25000), minority (69.1%), and female (58%) patients. Groups were similar except the intervention group had lower educational and income levels, while the control group was more likely to smoke more than 1 pack per day. Quit rates at 3 months were 27% and 19% in the intervention and control groups, respectively (p=0.22). Female gender (OR=2.84; p=0.04) and Fagerström score (OR=0.71; p<0.01) were significant predictors of quitting. CONCLUSIONS: The addition of Q&W to intensive smoking cessation services increased clinic referrals and numerically improved cessation rates, although this difference was not statistically significant, possibly due to high attrition of the study. European Publishing on behalf of the European Network for Smoking and Tobacco Prevention (ENSP) 2019-11-26 /pmc/articles/PMC7205166/ /pubmed/32411906 http://dx.doi.org/10.18332/tpc/113356 Text en © 2019 Evoy K.E https://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License.
spellingShingle Research Paper
Evoy, Kirk E.
Ford, Kentya H.
Nduaguba, Sabina 0.
Taylor, Amber
Thomas, Lindsay
A pilot study assessing the addition of a Quit and Win program to pharmacist-led intensive smoking cessation therapy in a predominantly underserved, minority population
title A pilot study assessing the addition of a Quit and Win program to pharmacist-led intensive smoking cessation therapy in a predominantly underserved, minority population
title_full A pilot study assessing the addition of a Quit and Win program to pharmacist-led intensive smoking cessation therapy in a predominantly underserved, minority population
title_fullStr A pilot study assessing the addition of a Quit and Win program to pharmacist-led intensive smoking cessation therapy in a predominantly underserved, minority population
title_full_unstemmed A pilot study assessing the addition of a Quit and Win program to pharmacist-led intensive smoking cessation therapy in a predominantly underserved, minority population
title_short A pilot study assessing the addition of a Quit and Win program to pharmacist-led intensive smoking cessation therapy in a predominantly underserved, minority population
title_sort pilot study assessing the addition of a quit and win program to pharmacist-led intensive smoking cessation therapy in a predominantly underserved, minority population
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205166/
https://www.ncbi.nlm.nih.gov/pubmed/32411906
http://dx.doi.org/10.18332/tpc/113356
work_keys_str_mv AT evoykirke apilotstudyassessingtheadditionofaquitandwinprogramtopharmacistledintensivesmokingcessationtherapyinapredominantlyunderservedminoritypopulation
AT fordkentyah apilotstudyassessingtheadditionofaquitandwinprogramtopharmacistledintensivesmokingcessationtherapyinapredominantlyunderservedminoritypopulation
AT nduagubasabina0 apilotstudyassessingtheadditionofaquitandwinprogramtopharmacistledintensivesmokingcessationtherapyinapredominantlyunderservedminoritypopulation
AT tayloramber apilotstudyassessingtheadditionofaquitandwinprogramtopharmacistledintensivesmokingcessationtherapyinapredominantlyunderservedminoritypopulation
AT thomaslindsay apilotstudyassessingtheadditionofaquitandwinprogramtopharmacistledintensivesmokingcessationtherapyinapredominantlyunderservedminoritypopulation
AT evoykirke pilotstudyassessingtheadditionofaquitandwinprogramtopharmacistledintensivesmokingcessationtherapyinapredominantlyunderservedminoritypopulation
AT fordkentyah pilotstudyassessingtheadditionofaquitandwinprogramtopharmacistledintensivesmokingcessationtherapyinapredominantlyunderservedminoritypopulation
AT nduagubasabina0 pilotstudyassessingtheadditionofaquitandwinprogramtopharmacistledintensivesmokingcessationtherapyinapredominantlyunderservedminoritypopulation
AT tayloramber pilotstudyassessingtheadditionofaquitandwinprogramtopharmacistledintensivesmokingcessationtherapyinapredominantlyunderservedminoritypopulation
AT thomaslindsay pilotstudyassessingtheadditionofaquitandwinprogramtopharmacistledintensivesmokingcessationtherapyinapredominantlyunderservedminoritypopulation